Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Down 89.5% in February

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 400 shares, a decline of 89.5% from the January 31st total of 3,800 shares. Based on an average daily trading volume, of 5,400 shares, the short-interest ratio is currently 0.1 days.

Fidelity Disruptive Medicine ETF Stock Performance

Fidelity Disruptive Medicine ETF stock traded up $0.18 during trading hours on Friday, hitting $25.17. The company had a trading volume of 3,974 shares, compared to its average volume of 5,510. The firm has a market cap of $52.86 million, a P/E ratio of 43.85 and a beta of 0.94. Fidelity Disruptive Medicine ETF has a 1 year low of $23.32 and a 1 year high of $26.79. The company has a 50-day moving average price of $25.64 and a two-hundred day moving average price of $25.78.

Fidelity Disruptive Medicine ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 24th. Shareholders of record on Friday, December 20th were given a $0.112 dividend. This represents a $0.45 annualized dividend and a yield of 1.78%. This is a boost from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00. The ex-dividend date was Friday, December 20th.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC grew its holdings in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 200.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 61,342 shares of the company’s stock after purchasing an additional 40,924 shares during the quarter. Jane Street Group LLC owned approximately 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 at the end of the most recent reporting period.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.